-Search query
-Search result
Showing 1 - 50 of 51 items for (author: havenar-daughton & c)
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
PDB-8sx3:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
EMDB-24243:
RM12K in complex with BG505 SOSIP
Method: single particle / : Cottrell CA, Ward AB
EMDB-24244:
RM54B1 Fab in complex with BG505 SOSIP
Method: single particle / : Cottrell CA, Ward AB
EMDB-24245:
RM15E Fab in complex with BG505 SOSIP
Method: single particle / : Cottrell CA, Ward AB
EMDB-24246:
RM15A Fab in complex with BG505 SOSIP
Method: single particle / : Cottrell CA, Ward AB
EMDB-24247:
RM35A1 Fab in complex with BG505 SOSIP
Method: single particle / : Cottrell CA, Ward AB
EMDB-24533:
SARS-CoV-2 spike protein bound to the S2P6 and S2M11 Fab fragments
Method: single particle / : Sauer MM, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-24347:
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24365:
SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ra8:
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7ral:
SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)
Method: single particle / : Veesler D, Tortorici MA, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24299:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-24300:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Veesler D
EMDB-24301:
SARS-CoV-2 spike glycoprotein ectodomain in complex with the S2H97 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Veesler D
PDB-7r7n:
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
Method: single particle / : Park YJ, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22491:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22492:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22494:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22497:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22506:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22507:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22508:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22512:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22516:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22517:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv2:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv4:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jv6:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jva:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jvc:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
PDB-7jw0:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D
EMDB-22659:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22660:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-22668:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k43:
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k45:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
Method: single particle / : Tortorici MA, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-7k4n:
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
Method: single particle / : Tortorici M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-21864:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-21865:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-6wps:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
PDB-6wpt:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
Method: single particle / : Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)
EMDB-7875:
BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding
Method: single particle / : Ozorowski G, Steichen JM, Schief WR, Ward AB
EMDB-7876:
BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding
Method: single particle / : Ozorowski G, Steichen JM, Schief WR, Ward AB
EMDB-7884:
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragment antigen binding and base-binding RM20A3 fragment antigen binding
Method: single particle / : Torres JL, Ozorowski G, Steichen JM, Schief WR, Ward AB
EMDB-7885:
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragment antigen binding and base-binding RM20A3 fragment antigen binding
Method: single particle / : Torres JL, Ozorowski G, Steichen JM, Schief WR, Ward AB
PDB-6dfg:
BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding
Method: single particle / : Ozorowski G, Steichen JM, Schief WR, Ward AB
PDB-6dfh:
BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding
Method: single particle / : Ozorowski G, Steichen JM, Schief WR, Ward AB
PDB-6nf5:
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding and base-binding RM20A3 fragment antigen binding
Method: single particle / : Ozorowski G, Torres JL, Steichen JM, Schief WR, Ward AB
PDB-6nfc:
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragmentantigen binding and base-binding RM20A3 fragment antigen binding
Method: single particle / : Ozorowski G, Torres JL, Ward AB
Pages: